OM | Outset Medical, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.4700 - 0.5124
52 Week Range	0.4700 - 13.93
Beta	1.91
Implied Volatility	328.64%
IV Rank	88.50%
Day's Volume	1,439,721
Average Volume	1,955,337
Shares Outstanding	52,089,800
Market Cap	25,477,121
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2020-09-15

Valuation
Profitability
Growth
Health
P/E Ratio	-0.16
Forward P/E Ratio	N/A
EPS	-3.14
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	480
Country	USA
Website	OM

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

OM's peers: CLPT, INSP, NARI, SWAV, NVRO, SIBN, SGHT, KIDS, OFIX, NPCE, CVRX, NUVA, CNMD, LUNG

*Chart delayed

Analyzing fundamentals for OM we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see OM Fundamentals page.

Watching at OM technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on OM Technicals page.